SG Americas Securities LLC Has $869,000 Stake in Sanofi (NASDAQ:SNY)

SG Americas Securities LLC increased its position in shares of Sanofi (NASDAQ:SNY) by 19.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,008 shares of the company’s stock after purchasing an additional 2,940 shares during the period. SG Americas Securities LLC’s holdings in Sanofi were worth $869,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Charles Schwab Investment Management Inc. lifted its position in shares of Sanofi by 31.1% during the third quarter. Charles Schwab Investment Management Inc. now owns 139,505 shares of the company’s stock worth $8,040,000 after purchasing an additional 33,105 shares in the last quarter. Arkadios Wealth Advisors raised its holdings in Sanofi by 19.0% in the fourth quarter. Arkadios Wealth Advisors now owns 4,709 shares of the company’s stock worth $227,000 after purchasing an additional 751 shares during the period. Geode Capital Management LLC lifted its holdings in Sanofi by 7.1% during the third quarter. Geode Capital Management LLC now owns 254,738 shares of the company’s stock worth $14,681,000 after acquiring an additional 16,780 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Sanofi by 20.9% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock valued at $133,172,000 after purchasing an additional 399,301 shares in the last quarter. Finally, GFS Advisors LLC boosted its holdings in shares of Sanofi by 1,017.9% in the third quarter. GFS Advisors LLC now owns 12,800 shares of the company’s stock valued at $738,000 after buying an additional 11,655 shares during the period. Institutional investors own 14.04% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th.

Sanofi Stock Performance

Shares of Sanofi stock opened at $52.97 on Wednesday. The company’s 50 day moving average price is $48.90 and its two-hundred day moving average price is $52.22. The firm has a market capitalization of $134.43 billion, a P/E ratio of 27.03, a P/E/G ratio of 1.19 and a beta of 0.57. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $58.97. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.